Showing 641 - 660 results of 107,203 for search '(( 10 mg decrease ) OR ( 5 ((((mean decrease) OR (a decrease))) OR (we decrease)) ))', query time: 1.49s Refine Results
  1. 641

    Tau phosphorylation is decreased in neurons treated with 20 mM KCl. by Nguyen-Vi Mohamed (323606)

    Published 2017
    “…The phosphorylation of S199/S202, T181, T205 and S404 was not significantly affected by 10mM of KCl treatment whereas the phosphorylation of all these sites was decreased by 20mM of KCl treatment. The signal of the phospho-antibodies was normalized to that of total Tau (n = 5, mean ± SEM, unpaired t-test two-tailed, *<i>P</i> < 0.05, ***<i>P</i> < 0.001). …”
  2. 642

    The numbers of mature T cells from transgenic mice bearing mutated CD3ε were decreased, and they were actively proliferating in a homeostatic manner. by Yibing Wang (204330)

    Published 2009
    “…Fold decreases for the two populations are indicated. Data shown are for 8 tgε<sup>Mut</sup> mice and 13 wt control mice (4 BL6, 1 tgε<sup>WT</sup>cd3ε<sup>+/−</sup>, 5 tgε<sup>Mut</sup>cd3ε<sup>+/−</sup>, and 3 tgε<sup>WT</sup>). …”
  3. 643
  4. 644
  5. 645
  6. 646

    Structure of YOLOv5s-SBC. by Zhongjian Xie (4633099)

    Published 2024
    “…Compared to the original model, P-YOLOv5s-GRNF decreased parameters by 18%, decreased model size to 11.9MB, decreased FLOPs to 14.5G, and increased FPS by 4.3. …”
  7. 647

    Phenethyl isothiocyanate activates leptin signaling and decreases food intake by Miho Yagi (5921252)

    Published 2018
    “…Leptin is a weight-reducing hormone produced by adipose tissue, which decreases food intake <i>via</i> hypothalamic leptin receptors (Ob-Rb) and the Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) signaling pathway. …”
  8. 648
  9. 649
  10. 650

    A summary of the included study characteristics. by Zahra Tajik (20752452)

    Published 2025
    “…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
  11. 651
  12. 652
  13. 653

    Decrease in ΔΨ on transition from the oxidized to the reduced state. by Vitaly A. Selivanov (133548)

    Published 2011
    “…<p>(A) Predicted dynamics of the transition induced by addition of 2 mM succinate to mitochondria initially in the oxidized state in the presence of 5 mM pyruvate, under the conditions of various proton leaks through the inner menbrane, slow leak, k<sub>lk</sub> = 17000, and fast leak, k<sub>lk</sub> = 80000 mL/(s·mg prot) (eq.H.1). …”
  14. 654
  15. 655

    FTY720 decreased viability, proliferation, and motility and induced apoptosis in human hepatoblastoma cells. by Laura L. Stafman (6577184)

    Published 2019
    “…(B) Following 24 hours of treatment with FTY720, the proliferation of HuH6 cells measured using the CellTiter 96 cell proliferation assay was significantly decreased (IC<sub>50</sub> = 6.4 μM, p ≤ 0.05). (C) HuH6 cells were plated and allowed to reach 80% confluence, at which time the media was changed for fresh media (0, 5, or 8 μM FTY720) and a standard scratch wound was made. …”
  16. 656

    Dose-dependent increase in NREM sleep and decrease in wakefulness by <i>p</i>.<i>o</i>. administration of TEG in mice. by Mahesh K. Kaushik (3753871)

    Published 2017
    “…All administrations were done at the onset of dark period (17:00 h). Data presented as mean ± SEM; n = 6; *p≤0.05, **p≤0.01 vs vehicle by using paired t-test for time course data (C, D and E), and one-way ANOVA followed by least square difference (LSD) post-hoc test for dose-response data (F and G). # #p≤0.01 vs TEG (10 mg/head).…”
  17. 657
  18. 658
  19. 659

    Multicenter Phase 2 Trial of Sirolimus for Tuberous Sclerosis: Kidney Angiomyolipomas and Other Tumors Regress and VEGF- D Levels Decrease by Sandra L. Dabora (206838)

    Published 2011
    “…Kidney angiomyolipomas regrew when sirolimus was discontinued but responses tended to persist if treatment was continued after week 52. We observed regression of brain tumors (SEGAs) in 7/11 cases (26% mean decrease in diameter), regression of liver angiomyolipomas in 4/5 cases (32.1% mean decrease in longest diameter), subjective improvement in facial angiofibromas in 57%, and stable lung function in women with TSC/LAM (n = 15). …”
  20. 660